Found 5 matching trials
A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia PHASE3 The purpose of this study is to compare the efficacy and safety of 2 starti...
Show More Location
Cliniques Universitaire Saint-Luc (Site 058)
Learn More & Join Trial
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib PHASE2 This phase II trial studies how well ponatinib hydrochloride works as secon...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia PHASE2 This study will address the therapeutic activity and the safety/biological ...
Show More Location
Presidio Ospedaliero "Oncologico Businco" - Cagliari (CA)
Learn More & Join Trial
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia PHASE3 In this study, adults with newly-diagnosed Philadelphia Chromosome-positive...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Study in Adult Ph-positive ALL PHASE2 An Open Label, 3-arm, Randomised Phase II Study to Compare the Safety and E...
Show More Location
Multiple Locations
Learn More & Join Trial